These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12847523)

  • 1. Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing.
    Chao H; Mansfield SG; Bartel RC; Hiriyanna S; Mitchell LG; Garcia-Blanco MA; Walsh CE
    Nat Med; 2003 Aug; 9(8):1015-9. PubMed ID: 12847523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon.
    Liu L; Mah C; Fletcher BS
    Mol Ther; 2006 May; 13(5):1006-15. PubMed ID: 16464640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spliceosome-mediated RNA trans-splicing.
    Yang Y; Walsh CE
    Mol Ther; 2005 Dec; 12(6):1006-12. PubMed ID: 16226059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA repair for haemophilia A.
    Chao H; Walsh CE
    Expert Rev Mol Med; 2006 Jan; 8(1):1-8. PubMed ID: 16401355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
    Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
    J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coaxing coagulation with RNA and cell fragments.
    High KA
    Nat Med; 2003 Aug; 9(8):991-2. PubMed ID: 12894156
    [No Abstract]   [Full Text] [Related]  

  • 7. Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing.
    Mansfield SG; Kole J; Puttaraju M; Yang CC; Garcia-Blanco MA; Cohn JA; Mitchell LG
    Gene Ther; 2000 Nov; 7(22):1885-95. PubMed ID: 11127576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype correction of hemophilia A mice with adeno-associated virus vectors carrying the B domain-deleted canine factor VIII gene.
    Ishiwata A; Mimuro J; Kashiwakura Y; Niimura M; Takano K; Ohmori T; Madoiwa S; Mizukami H; Okada T; Naka H; Yoshioka A; Ozawa K; Sakata Y
    Thromb Res; 2006; 118(5):627-35. PubMed ID: 16371232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Generation of factor VIII gene knockout mouse by tetraploid embryo complementation technology].
    Kuang Y; Wang J; Lu X; Lu S; Zhang L; Shen C; Fei J; Wang Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):1-6. PubMed ID: 20140858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FVIII gene delivery by muscle electroporation corrects murine hemophilia A.
    Long YC; Jaichandran S; Ho LP; Tien SL; Tan SY; Kon OL
    J Gene Med; 2005 Apr; 7(4):494-505. PubMed ID: 15521095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spliceosome-mediated RNA trans-splicing as a tool for gene therapy.
    Puttaraju M; Jamison SF; Mansfield SG; Garcia-Blanco MA; Mitchell LG
    Nat Biotechnol; 1999 Mar; 17(3):246-52. PubMed ID: 10096291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an adenoviral vector encoding full-length human factor VIII in hemophiliac mice.
    Connelly S; Andrews JL; Gallo-Penn AM; Tagliavacca L; Kaufman RJ; Kaleko M
    Thromb Haemost; 1999 Feb; 81(2):234-9. PubMed ID: 10063998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical animal models for hemophilia gene therapy: predictive value and limitations.
    Rawle FE; Lillicrap D
    Semin Thromb Hemost; 2004 Apr; 30(2):205-13. PubMed ID: 15118932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy.
    Youjin S; Jun Y
    Biotechnol Lett; 2009 Mar; 31(3):321-8. PubMed ID: 18979215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral modification of mesenchymal stem cells for gene therapy of hemophilia.
    Doering CB
    Methods Mol Biol; 2008; 433():203-12. PubMed ID: 18679625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene.
    Chao BN; Baldwin WH; Healey JF; Parker ET; Shafer-Weaver K; Cox C; Jiang P; Kanellopoulou C; Lollar P; Meeks SL; Lenardo MJ
    J Thromb Haemost; 2016 Feb; 14(2):346-55. PubMed ID: 26588198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained expansion and transgene expression of coagulation factor VIII-transduced cord blood-derived endothelial progenitor cells.
    Herder C; Tonn T; Oostendorp R; Becker S; Keller U; Peschel C; Grez M; Seifried E
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2266-72. PubMed ID: 14551158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of human coagulation factor VIII in adipocytes transduced with the simian immunodeficiency virus agmTYO1-based vector for hemophilia A gene therapy.
    Ogata K; Mimuro J; Kikuchi J; Tabata T; Ueda Y; Naito M; Madoiwa S; Takano K; Hasegawa M; Ozawa K; Sakata Y
    Gene Ther; 2004 Feb; 11(3):253-9. PubMed ID: 14737084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing.
    Puttaraju M; DiPasquale J; Baker CC; Mitchell LG; Garcia-Blanco MA
    Mol Ther; 2001 Aug; 4(2):105-14. PubMed ID: 11482981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exon skipping partially restores factor VIII coagulant activity in patients with mild hemophilia A with exon 13 duplication.
    Acquila M; Pasino M; Lanza T; Molinari AC; Rosano C; Bicocchi MP
    Haematologica; 2005 Jul; 90(7):997-9. PubMed ID: 15996947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.